Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
09/2003
09/16/2003US6620915 Monoclonal antibodies specific for integrin α-d subunit
09/16/2003US6620784 Uses of VEGF-E
09/16/2003US6620783 Human SMN-like protein (HSLP) and polynucleotides which identify and encode HSLP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating
09/16/2003US6620778 Cysteine/glycine rich peptides
09/16/2003US6620610 For the preparation of transgenic crop plants, such as tobacco, potatoes, beets and maize with increased yield, by altering their nitrogen metabolism
09/16/2003US6620587 Ribosome complexes as selection particles for in vitro display and evolution of proteins
09/16/2003CA2145985C Vascular endothelial cell growth factor antagonists
09/16/2003CA2140252C A snow grooming device
09/16/2003CA2131719C Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor
09/16/2003CA2119463C Glial cell line-derived neutrophic factor
09/16/2003CA2054590C Novel cyclosporins
09/12/2003WO2003075006A1 Determination of compatibility of a set of chemical modifications with an amino-acid chain
09/12/2003WO2003074726A2 Immune response associated proteins
09/12/2003WO2003074702A1 Novel protein and dna thereof
09/12/2003WO2003074697A1 Method of modifying protein properties
09/12/2003WO2003074694A1 Adipocyte differentiation-associated genes and proteins
09/12/2003WO2003074687A1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
09/12/2003WO2003074681A1 Recombinant spores
09/12/2003WO2003074678A2 Modular recombinatorial display libraries
09/12/2003WO2003074670A2 Lis promoter for expression of transgenes in floral tissues
09/12/2003WO2003074657A2 Cold shock inducible expression and production of heterologous polypeptides
09/12/2003WO2003074564A1 Novel hemepeptide
09/12/2003WO2003074546A2 Streptavidin-binding peptide
09/12/2003WO2003074081A1 SPECIFIC ANTIBODIES TO AMYLOID β PEPTIDE, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF
09/12/2003WO2003074073A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
09/12/2003WO2003073982A2 Anti-interleukin-1 beta analogs
09/12/2003WO2003073980A2 Recombinant protein c variants
09/12/2003WO2003073821A2 Shc PROTEIN-RELATED METHODS AND COMPOSITIONS FOR THE PROGNOSIS OF BREAST, PROSTATE AND OVARIAN CANCER
09/12/2003WO2003065973A8 Multivalent streptococcal vaccine compositions and methods for use
09/12/2003WO2003046133A3 Regulatory nucleic acid assay for diagnostic and library screens
09/12/2003WO2003032814A3 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof
09/12/2003WO2003011893A3 Immunologically significant herpes simplex virus antigens and methods for using same
09/12/2003WO2002082041A3 Production and use of novel peptide-based agents for use with bi-specific antibodies
09/12/2003WO2002075507A3 Anti-bacterial vaccine compositions
09/12/2003WO2002072830A3 Proteins associated with cell growth, differentiation, and death
09/12/2003WO2002048370A3 Compositions and methods relating to colon specific genes and proteins
09/12/2003WO2002032961A8 Novel polypeptides and nucleic acids encoding same
09/12/2003CA2818688A1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
09/12/2003CA2477953A1 Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer
09/12/2003CA2477947A1 Modular recombinatorial display libraries
09/12/2003CA2477876A1 Recombinant protein c variants
09/12/2003CA2477856A1 Cold shock inducible expression and production of heterologous polypeptides
09/12/2003CA2477794A1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
09/12/2003CA2477662A1 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
09/12/2003CA2477621A1 Determination of compatibility of a set of chemical modifications with an amino-acid chain
09/12/2003CA2477442A1 Lis promoter for expression of transgenes in floral tissues
09/11/2003US20030172408 Transcription factor stress-related polypeptides and methods of use in plants
09/11/2003US20030172389 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
09/11/2003US20030171568 Diagnosing tumor or cancer in a mammal, and inflammatory diseases or disorders; inflammatory bowel disease, colon cancer; immunoassay, immunotherapy
09/11/2003US20030171567 Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
09/11/2003US20030171566 An isolated human nucleic acid encoding a nevoid basal cell carcinoma syndrome protein, antibodies, detecting tumor protein, therapeutic treatment of tumor, cancer; genetic engineering
09/11/2003US20030171559 A colony-stimulating factor hybrid molecules, computer analyzing the three dimensional structure protein, crystallization of the protein
09/11/2003US20030171556 Diagnosis and therapeutic treatment of Alzheimer's Disease; drug screening
09/11/2003US20030171552 A single-chain T-cell receptor covalently linked to single-chain antibody; anticarcinogenic agents for treating cancer
09/11/2003US20030171550 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/11/2003US20030171548 Immunoreactive proteins where the percentage of immuno-reactive molecules as determined in a modified Lindmo-test is >81%; fermentation of culture of fluidized reactor; diagnosis of inflammatory and bone marrow displacing process
09/11/2003US20030171547 Adipocyte-specific protein homologs
09/11/2003US20030171541 Selective binding agents, vectors, host cells, and methods for producing GPCR polypeptides; diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with GPCR polypeptides
09/11/2003US20030171435 New amphetamine derivatives, antibodies against them and pharmaceutical compositions containing them
09/11/2003US20030171328 Non-invasive method for detecting target-RNA
09/11/2003US20030171326 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
09/11/2003US20030171319 Human chemokine beta-10 mutant polypeptides
09/11/2003US20030171290 Methods to determine peptides presented on the surface of mammalian cells following addition to the cells of a protein. The present invention also relates to diagnostic tests based on the determination of such peptides or modified molecules
09/11/2003US20030171278 Novel compounds which bind to the human erbB2 gene product (ErbB2, also known as HER2, or c-ErbB-2). In particular aspects, the invention provides for the treatment of disorders characterized by the overexpression of ErbB2 utilizing the
09/11/2003US20030171274 Antimicrobial proteins
09/11/2003US20030171273 DNA of SEQ ID NO:1 is provided that encodes the transcription factor BP1, which is believed to be a repressor of the beta -globin gene. A host cell that is transformed with a vector that contains the DNA may be used to produce BP1.
09/11/2003US20030171269 Novel epidermal growth factor protein and gene, and methods of use therefor
09/11/2003US20030171256 Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals
09/11/2003US20030171254 Purified outer membrane protein of a Moraxella strain, particularly M. catarrhalis, having a molecular mass of about 200 kDa, is provided. The about 200 kDa outer membrane protein as well as nucleic acid molecules encoding the same are useful
09/11/2003US20030171252 Nucleic acid molecules are provided encoding novel polypeptides. Novel polypeptides and antibodies that bind to these polypeptides are provided. Also provided are vectors, host cells, and recombinant and synthetic methods for human
09/11/2003US20030170917 4-Hydroxyalkylphenethamines, used as an intermediate, hapten, or immunogen in the production of antibodies specific for ecstasy drugs; binding the antibody to the analyte and detecting the adduct formed; immunoassay
09/11/2003US20030170896 Adeno-asociated virus (AAV) vectors that are capable of being transferred between cells; used to support comercially significant levels or rAAV particles without infectious helper virus or other harmful by-products
09/11/2003US20030170867 Novel thermostable proteolytic enzymes and uses thereof in peptide and protein synthesis
09/11/2003US20030170865 Novel polypeptide of protein p140 and DNAs encoding it
09/11/2003US20030170864 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/11/2003US20030170863 Prevents side effects such as systemic activation of coagulation system, bleeding
09/11/2003US20030170860 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
09/11/2003US20030170859 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders
09/11/2003US20030170840 Genomic mammary amyloid a sequence
09/11/2003US20030170839 Type 2 cytokine receptor and nucleic acids encoding same
09/11/2003US20030170838 Novel polynucleotides and polypeptides encoded thereby
09/11/2003US20030170825 Comprises antihemophilic factor (factor VIII) and antitrypsin signal sequences; for treatment of hemophilia
09/11/2003US20030170813 Culturing a genetically recombinant host where the sugar chain structure is modified by changing the consumption rate in the medium;
09/11/2003US20030170812 Interleukin-1beta converting enzyme like cysteine protease
09/11/2003US20030170811 Culturing a microorganism transformed with an expression vector comprising a gene encoding an amino acid sequence of a peptide-fused atriopeptin; use as antihypertensive diuretic agent
09/11/2003US20030170809 Of given amino acid sequence; use in stimulating cell proliferation and differentiation and in diagnosing tumors
09/11/2003US20030170808 Polypeptide encoded by polynucleotide of given sequence; use in diagnosis and treatment of various diseases
09/11/2003US20030170792 MAGE-3 peptides presented by HLA class ll molecules
09/11/2003US20030170790 Of given amino acid sequence; use in modulating cell activity, stimulating release of tumor necrosis factor, proteoglycans and cytokines; detecting tumors
09/11/2003US20030170789 Of given amino acid sequence; use in modulating cell activity, stimulating release of tumor necrosis factor, proteoglycans and cytokines; detecting tumors
09/11/2003US20030170788 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/11/2003US20030170782 Proteins
09/11/2003US20030170763 Protein antiallergens
09/11/2003US20030170754 Anticancer agents; diagnosis of prostate cancer
09/11/2003US20030170749 Detection using antibodies; parasiticides; veterinary medicine
09/11/2003US20030170721 Bonding to antibodies; genetic engineering
09/11/2003US20030170718 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/11/2003US20030170708 Screening for mutants; primer amplification
09/11/2003US20030170697 Detection and treatment of infections with immunoconjugates
09/11/2003US20030170663 Nucleotide sequence of the Mycoplasma genitalium genome, fragments thereof, and uses thereof
1 ... 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 ... 1125